Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Publication Preview--Ahead of Print
    • Past Issue Archive
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
  • For Authors
  • About Us
    • About AJNR
    • Editors
    • American Society of Neuroradiology
  • Submit a Manuscript
  • Podcasts
    • Subscribe on iTunes
    • Subscribe on Stitcher
  • More
    • Subscribers
    • Permissions
    • Advertisers
    • Alerts
    • Feedback
  • Other Publications
    • ajnr

User menu

  • Subscribe
  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

  • Subscribe
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Publication Preview--Ahead of Print
    • Past Issue Archive
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
  • For Authors
  • About Us
    • About AJNR
    • Editors
    • American Society of Neuroradiology
  • Submit a Manuscript
  • Podcasts
    • Subscribe on iTunes
    • Subscribe on Stitcher
  • More
    • Subscribers
    • Permissions
    • Advertisers
    • Alerts
    • Feedback
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds
Research ArticleADULT BRAIN
Open Access

COVID-19–Associated PRES–like Encephalopathy with Perivascular Gadolinium Enhancement

G. Conte, S. Avignone, M. Carbonara, M. Meneri, F. Ortolano, C. Cinnante and F. Triulzi
American Journal of Neuroradiology August 2020, DOI: https://doi.org/10.3174/ajnr.A6762
G. Conte
aFrom the Neuroradiology Unit (G.C., S.A., C.C., F.T.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for G. Conte
S. Avignone
aFrom the Neuroradiology Unit (G.C., S.A., C.C., F.T.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for S. Avignone
M. Carbonara
bNeuroscience Intensive Care Unit (M.C., F.O.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for M. Carbonara
M. Meneri
cDepartment of Anesthesia and Critical Care, and Neurology Unit (M.M.), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for M. Meneri
F. Ortolano
bNeuroscience Intensive Care Unit (M.C., F.O.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for F. Ortolano
C. Cinnante
aFrom the Neuroradiology Unit (G.C., S.A., C.C., F.T.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for C. Cinnante
F. Triulzi
aFrom the Neuroradiology Unit (G.C., S.A., C.C., F.T.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for F. Triulzi
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • References
  • PDF
Loading

Abstract

SUMMARY: We describe the case of a 63-year-old woman who developed a coronavirus disease 2019–associated acute encephalopathy with perivascular gadolinium enhancemsent.

ABBREVIATIONS:

ICU
intensive care unit
PRES
posterior reversible encephalopathy syndrome
SARS-Cov-2
Severe Acute Respiratory Syndrome coronavirus 2

A 63-year-old woman was admitted to our hospital on day 7 (day 1 is the first day of symptoms) with fever, dry cough, fatigue, and subjective dyspnea. A nasopharyngeal swab for Severe Acute Respiratory Syndrome coronavirus 2 (SARS-Cov-2) was positive. Arterial blood gas analysis in room air showed mild hypocapnia (partial pressure of carbon dioxide, 31), causing mild respiratory alkalosis (pH = 7.48) and a low level of oxygen (partial pressure of carbon dioxide, 67). A chest x-ray was performed, showing bilateral ground-glass opacities. The patient had hypertension, but no other comorbidities were identified.

She was first admitted to the emergency ward and treated with a continuous positive airway pressure helmet; lopinavir/ritonavir was started as compassionate use approved by the ethics committee, as well as empirical piperacillin-tazobactam. Her respiratory parameters progressively worsened during the next days until she showed dyspnea, and her PaO2/FiO2 ratio was 110 with a continuous positive airway pressure helmet at 15 cm of water and an inspiratory fraction of oxygen of 70%. On day 11, she was intubated and transferred to the intensive care unit (ICU). During her ICU stay, she initially received mechanical ventilation at a medium level of positive end-expiratory pressure (up to 14) and inhaled nitric oxide and underwent two 20-hour prone-position cycles. She also developed a moderately acute kidney injury (measured creatinine clearance of 28 mL/minute), which never required replacement therapy, and high levels of hepatic enzymes and bilirubin, which caused us to stop lopinavir/ritonavir. An angiotensin-converting-enzyme inhibitor was introduced to reduce blood pressure in the ventilator weaning phase after 15 days on sedative drugs and opioids.

Regarding the treatment given in the ICU that was different from the usual care, she received anakinra (an interleukin 1 antagonist) due to a persistent high level of C-reactive Protein and ferritin and a high dose of subcutaneous heparin to target an activated partial thromboplastin time ratio of 2. On day 24, antibiotics were suspended until she developed ventilator-associated pneumonia by methicillin-sensitive Staphylococcus aureus, and cefazolin was given. Gradually, her clinical conditions improved, and she was weaned from the ventilator on day 28, after 24 hours of spontaneous breathing. On day 29, she was transferred back to medium intensity care in relatively good condition: afebrile, low-flow oxygen therapy via nasal cannula with normal peripheral capillary oxygen saturation and respiratory mechanics, normal blood pressure, and diuresis with acute kidney and hepatic injuries improving.

On day 30, she presented with left head and eye deviation and continuous tonic seizures on the left side of the body. After ineffective treatment with diazepam and lacosamide, the patient was sedated, intubated, and transferred again to the ICU. A phenytoin IV load was started, followed by enteral maintenance dosages, associated with diazepam infusion with clinical resolution. An electroencephalogram showed periodic lateralized epileptiform discharges in the right posterior regions, without clinical correlation. A lumbar puncture revealed only a slightly elevated protein level (70 mg/dL). A polymerase chain reaction test for virus detection in the CSF, including SARS-Cov-2, was negative. MR imaging showed cortical swelling and restricted diffusivity in the posterior regions of the right hemisphere, corresponding to the epileptic focus (On-line Figure). We observed multiple, partially confluent, tumefactive lesions of the sub- and supratentorial white matter hemispheres, with prevalence in the posterior hemisphere regions, which appeared as increased signal intensity on T2-weighted images, consistent with brain edema. The susceptibility-weighted images showed a subarachnoid blood effusion along the left precentral sulcus and excluded intraparenchymal hemorrhagic petecchiae. MR venography excluded intracranial thrombosis (Fig 1). The contrast-enhanced T1-weighted black-blood sequence showed a miliariform perivascular gadolinium enhancement in the supra- and subtentorial white matter. Neither wall enhancement of the large intracranial arterial vessels nor leptomeningeal enhancement was observed on postcontrast sequences (Fig 2).

FIG 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIG 1.

The FLAIR sequence shows multiple lesions of the white matter of both hemispheres (A–C), more striking in the posterior regions with a tumefactive appearance (long arrows) and with a multifocal perivascular pattern in the deep white matter regions (short arrows). The lesions (arrows) show high values on the apparent diffusion coefficient map (D), suggesting increased water content in the parenchyma. The SWI sequence (E) shows a subarachnoid blood effusion along the left precentral sulcus (arrow). MR venography (F) excludes intracranial thrombosis.

FIG 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIG 2.

The contrast-enhanced 3D conventional T1-weighted sequence (A–C) shows multiple spotlike gadolinium enhancement (arrows) in the posterior white matter and left hemisphere. The postcontrast 3D-T1-weighted black-blood sequence (D–F) shows a stratiform perivascular gadolinium enhancement in the white matter of both cerebral hemispheres. Neither wall enhancement of the large intracranial arterial vessels nor leptomeningeal enhancement are observed on postcontrast sequences.

The patient gradually improved. On day 41, she was extubated and was discharged to the ward 2 days later with residual mild left hemiparesis and left lateral hemianopsia. A control electroencephalogram showed only sporadic sharp waves and spikes in the right posterior regions. At follow-up, on MR imaging on day 49, the cerebellar lesions disappeared, cerebral lesions were markedly reduced, perivascular enhancement was not detected, and diffusion-weighted imaging findings were negative. On day 61, the patient was discharged from the hospital and referred to rehabilitation. At 180-day follow-up, the patient was at home, without motor deficits but with partial visual loss in the left eye (extended Glasgow Outcome Scale, 4; mRS score, 3).

We made a diagnosis of posterior reversible encephalopathy syndrome (PRES)-like encephalopathy with peculiar MR imaging findings. The miliariform perivascular postgadolinium enhancement has not previously been reported among typical and atypical MR imaging findings in PRES.1,2 The perivascular enhancement might be a sign of immune-mediated small-vessel damage, leading to altered integrity of the blood-brain barrier and brain edema, as supposed in PRES.3

Footnotes

  • Disclosures: Marco Carbonara—UNRELATED: Travel/Accommodations/Meeting Expenses Unrelated to Activities Listed: European Union, Comments: In the context of CENTER-TB1–related activities.

Indicates open access to non-subscribers at www.ajnr.org

References

  1. 1.↵
    1. Bartynski WS
    . Posterior reversible encephalopathy syndrome, Part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol 2008;29:1036–42 doi:10.3174/ajnr.A0928 pmid:18356474
    Abstract/FREE Full Text
  2. 2.↵
    1. Saad AF,
    2. Chaudhari R,
    3. Wintermark M
    . Imaging of atypical and complicated posterior reversible encephalopathy syndrome. Front Neurol 2019;10:964 doi:10.3389/fneur.2019.00964 pmid:31551919
    CrossRefPubMed
  3. 3.↵
    1. Fugate JE,
    2. Rabinstein AA
    . Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol 2015;14:914–25 doi:10.1016/S1474-4422(15)00111-8 pmid:26184985
    CrossRefPubMed
  • Received June 6, 2020.
  • Accepted after revision July 14, 2020.
  • © 2020 by American Journal of Neuroradiology
View Abstract
PreviousNext
Back to top
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
COVID-19–Associated PRES–like Encephalopathy with Perivascular Gadolinium Enhancement
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
COVID-19–Associated PRES–like Encephalopathy with Perivascular Gadolinium Enhancement
G. Conte, S. Avignone, M. Carbonara, M. Meneri, F. Ortolano, C. Cinnante, F. Triulzi
American Journal of Neuroradiology Aug 2020, DOI: 10.3174/ajnr.A6762

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
COVID-19–Associated PRES–like Encephalopathy with Perivascular Gadolinium Enhancement
G. Conte, S. Avignone, M. Carbonara, M. Meneri, F. Ortolano, C. Cinnante, F. Triulzi
American Journal of Neuroradiology Aug 2020, DOI: 10.3174/ajnr.A6762
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Purchase

Jump to section

  • Article
    • Abstract
    • ABBREVIATIONS:
    • Footnotes
    • References
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • References
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Crossref
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

More in this TOC Section

  • MGMT Promoter Methylation Status in Initial and Recurrent Glioblastoma: Correlation Study with DWI and DSC PWI Features
  • Traumatic Cerebral Microbleeds in the Subacute Phase Are Practical and Early Predictors of Abnormality of the Normal-Appearing White Matter in the Chronic Phase
  • CTA Evaluation of Basilar Septations: An Entity Better Characterized as Aberrant Basilar Fenestrations
Show more ADULT BRAIN

Similar Articles

Advertisement

News and Updates

  • Lucien Levy Best Research Article Award
  • Thanks to our 2020 Distinguished Reviewers
  • Press Releases

Resources

  • Evidence-Based Medicine Level Guide
  • How to Participate in a Tweet Chat
  • AJNR Podcast Archive
  • Ideas for Publicizing Your Research
  • Librarian Resources
  • Terms and Conditions

Opportunities

  • Share Your Art in Perspectives
  • Get Peer Review Credit from Publons
  • Moderate a Tweet Chat

American Society of Neuroradiology

  • Neurographics
  • ASNR Annual Meeting
  • Fellowship Portal
  • Position Statements

© 2021 by the American Society of Neuroradiology | Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire